During the past decade, Community Consortium / UCSF conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Community Consortium / UCSF" are "HIV Infections" (14 trials), "Mycobacterium Avium-intracellulare Infection" (2 trials), "Cytomegalovirus Infections" (1 trials), "HIV Wasting Syndrome" (1 trials) and "Pneumococcal Infections" (1 trials). Many other conditions were trialed in "Community Consortium / UCSF" in a lesser frequency.

Most popular intervention types in "Community Consortium / UCSF" are "Drug" (7 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Indinavir sulfate" (3 trials), "Nelfinavir mesylate" (3 trials), "Efavirenz" (2 trials), "Ritonavir" (2 trials) and "Abacavir sulfate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Community Consortium / UCSF" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Community Consortium / UCSF". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Community Consortium / UCSF, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Community Consortium / UCSF, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".